For nearly two decades Cleveland Clinic Innovations (CCI), the hospital group’s commercialization arm, has looked to invest in and develop new medical technologies into market-ready products.
While many of these innovations have been the product of in-house inventors, Pete O’Neill, executive director of CCI, said that his organization has found external innovation partnerships to be especially...
Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
“I am proud of the substantial progress OWKIN has made over the last year,...